-
Je něco špatně v tomto záznamu ?
Dibasic Derivatives of Phenylcarbamic Acid as Prospective Antibacterial Agents Interacting with Cytoplasmic Membrane
Š. Pospíšilová, I. Malik, K. Bezouskova, T. Kauerova, P. Kollar, J. Csöllei, M. Oravec, A. Cizek, J. Jampilek,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
FaF UK/26/2019
Faculty of Pharmacy, Comenius University in Bratislava
APVV-14-0547
Slovak Research and Development Agency
LO1305
Ministry of Education of the Czech Republic
CZ.02.1.01/0.0/0.0/16_013/0001609
CzeCOS ProCES
LO1415
National Sustainability Program I
NLK
Directory of Open Access Journals
od 2012
PubMed Central
od 2012
Europe PubMed Central
od 2012
ProQuest Central
od 2012-01-01
Open Access Digital Library
od 2012-01-01
Open Access Digital Library
od 2012-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2012
- Publikační typ
- časopisecké články MeSH
1-[2-[({[2-/3-(Alkoxy)phenyl]amino}carbonyl)oxy]-3-(dipropylammonio)propyl]pyrrolidinium/azepan- ium oxalates or dichlorides (alkoxy = butoxy to heptyloxy) were recently described as very promising antimycobacterial agents. These compounds were tested in vitro against Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 (reference and control strains), three methicillin-resistant isolates of S. aureus, and three isolates of vancomycin-resistant E. faecalis. 1-[3-(Dipropylammonio)-2-({[3-(pentyloxy-/hexyloxy-/heptyloxy)phenyl]carbamoyl}oxy)propyl]pyrrolidinium dichlorides showed high activity against staphylococci and enterococci comparable with or higher than that of used controls (clinically used antibiotics and antiseptics). The screening of the cytotoxicity of the compounds as well as the used controls was performed using human monocytic leukemia cells. IC50 values of the most effective compounds ranged from ca. 3.5 to 6.3 µM, thus, it can be stated that the antimicrobial effect is closely connected with their cytotoxicity. The antibacterial activity is based on the surface activity of the compounds that are influenced by the length of their alkoxy side chain, the size of the azacyclic system, and hydro-lipophilic properties, as proven by in vitro experiments and chemometric principal component analyses. Synergistic studies showed the increased activity of oxacillin, gentamicin, and vancomycin, which could be explained by the direct activity of the compounds against the bacterial cell wall. All these compounds demonstrate excellent antibiofilm activity, when they inhibit and disrupt the biofilm of S. aureus in concentrations close to minimum inhibitory concentrations against planktonic cells. Expected interactions of the compounds with the cytoplasmic membrane are proven by in vitro crystal violet uptake assays.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005214
- 003
- CZ-PrNML
- 005
- 20200528095255.0
- 007
- ta
- 008
- 200511s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/antibiotics9020064 $2 doi
- 035 __
- $a (PubMed)32041117
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pospíšilová, Šárka $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic.
- 245 10
- $a Dibasic Derivatives of Phenylcarbamic Acid as Prospective Antibacterial Agents Interacting with Cytoplasmic Membrane / $c Š. Pospíšilová, I. Malik, K. Bezouskova, T. Kauerova, P. Kollar, J. Csöllei, M. Oravec, A. Cizek, J. Jampilek,
- 520 9_
- $a 1-[2-[({[2-/3-(Alkoxy)phenyl]amino}carbonyl)oxy]-3-(dipropylammonio)propyl]pyrrolidinium/azepan- ium oxalates or dichlorides (alkoxy = butoxy to heptyloxy) were recently described as very promising antimycobacterial agents. These compounds were tested in vitro against Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 (reference and control strains), three methicillin-resistant isolates of S. aureus, and three isolates of vancomycin-resistant E. faecalis. 1-[3-(Dipropylammonio)-2-({[3-(pentyloxy-/hexyloxy-/heptyloxy)phenyl]carbamoyl}oxy)propyl]pyrrolidinium dichlorides showed high activity against staphylococci and enterococci comparable with or higher than that of used controls (clinically used antibiotics and antiseptics). The screening of the cytotoxicity of the compounds as well as the used controls was performed using human monocytic leukemia cells. IC50 values of the most effective compounds ranged from ca. 3.5 to 6.3 µM, thus, it can be stated that the antimicrobial effect is closely connected with their cytotoxicity. The antibacterial activity is based on the surface activity of the compounds that are influenced by the length of their alkoxy side chain, the size of the azacyclic system, and hydro-lipophilic properties, as proven by in vitro experiments and chemometric principal component analyses. Synergistic studies showed the increased activity of oxacillin, gentamicin, and vancomycin, which could be explained by the direct activity of the compounds against the bacterial cell wall. All these compounds demonstrate excellent antibiofilm activity, when they inhibit and disrupt the biofilm of S. aureus in concentrations close to minimum inhibitory concentrations against planktonic cells. Expected interactions of the compounds with the cytoplasmic membrane are proven by in vitro crystal violet uptake assays.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Malik, Ivan $u Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University in Bratislava, Odbojarov 10, 832 32 Bratislava, Slovakia.
- 700 1_
- $a Bezouskova, Kristyna $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1946/1, 612 42 Brno, Czech Republic.
- 700 1_
- $a Kauerova, Tereza $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic.
- 700 1_
- $a Kollar, Peter $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Palackeho 1, 61242 Brno, Czech Republic.
- 700 1_
- $a Csöllei, Jozef $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences in Brno, Palackeho 1946/1, 612 42 Brno, Czech Republic.
- 700 1_
- $a Oravec, Michal $u Global Change Research Institute CAS, Belidla 986/4a, 603 00 Brno, Czech Republic.
- 700 1_
- $a Cizek, Alois $u Department of Infectious Diseases and Microbiology, Faculty of Veterinary Medicine, University of Veterinary and Pharmaceutical Sciences, Palackeho 1946/1, 612 42 Brno, Czech Republic.
- 700 1_
- $a Jampilek, Josef $u Regional Centre of Advanced Technologies and Materials, Faculty of Science, Palacky University, Slechtitelu 27, 783 71 Olomouc, Czech Republic. Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 845 10 Bratislava, Slovakia.
- 773 0_
- $w MED00195446 $t Antibiotics (Basel, Switzerland) $x 2079-6382 $g Roč. 9, č. 2 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32041117 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200528095253 $b ABA008
- 999 __
- $a ind $b bmc $g 1524144 $s 1095269
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 9 $c 2 $e 20200206 $i 2079-6382 $m Antibiotics (Basel) $n Antibiotics $x MED00195446
- GRA __
- $a FaF UK/26/2019 $p Faculty of Pharmacy, Comenius University in Bratislava
- GRA __
- $a APVV-14-0547 $p Slovak Research and Development Agency
- GRA __
- $a LO1305 $p Ministry of Education of the Czech Republic
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_013/0001609 $p CzeCOS ProCES
- GRA __
- $a LO1415 $p National Sustainability Program I
- LZP __
- $a Pubmed-20200511